INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / GLOBAL EX US HGH
Total 13F shares
3,584,367
Share change
-897,308
Total reported value
$70,010,788
Price per share
$19.53
Number of holders
59
Value change
-$17,530,782
Number of buys
25
Number of sells
22

Institutional Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q4 2023

As of 31 Dec 2023, INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,584,367 shares. The largest 10 holders included Sowell Financial Services LLC, Whitcomb & Hess, Inc., Essex LLC, MORGAN STANLEY, LPL Financial LLC, AE Wealth Management LLC, Royal Fund Management, LLC, OLIVER LAGORE VANVALIN INVESTMENT GROUP, JANE STREET GROUP, LLC, and Kingsview Wealth Management, LLC. This page lists 60 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.